Fingerprint
Dive into the research topics of 'Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
Robert Croop, Richard B. Lipton, David Kudrow, David A. Stock, Lisa Kamen, Charles M. Conway, Elyse G. Stock, Vladimir Coric, Peter J. Goadsby
Research output: Contribution to journal › Article › peer-review
188
Scopus
citations